Versions :1 2 3 4 5 6 7 8 Live >

Snapshot 1:Mon, Nov 24, 2025 4:48:52 PM GMT last edited by Vandita

Novo Nordisk GLP-1 Drug Alzheimer's Trials Fail

Published 1 day ago

story

Image credit:

Articles on this story

Novo Nordisk Lottery Ticket Alzheimers Trials Fail Deliver Reward

Reuters1 day

Novo Nordisk stock plummets 12.4% after weight-loss pill Ozempic fails Alzheimer's trials — All you need to know

MINT1 day

ProfRobHoward

X1 day

Novo Nordisk shares slump after drug failure in Alzheimer’s trial

Financial Times1 day

Novo Nordisk Plunges After Ozempic Pill Fails Alzheimer's Trials - Shares Suffer Worst Year Ever

ZeroHedge1 day

AlzResearchUK

X1 day

Novo Nordisk GLP-1 Drug Alzheimer's Trials Fail

Newsmax1 day

Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials

Wall Street Journal1 day

expert reaction to news from Novo Nordisk that semaglutide does not reduce Alzheimers Disease progression

Science Media Centre1 day

News Details

Novo Nordisk1 day

Semaglutide fails to slow progression of Alzheimers in highly anticipated trials, Novo Nordisk says

CNN1 day

Novo Nordisk says Alzheimer's trial with older GLP-1 drug fails

NBC1 day

Novo Nordisk shares plunge to four-year low after Alzheimer’s drug trial fails to hit key target

CNBC1 day

Novo Nordisk shares slide after Ozempic pill fails in Alzheimers trials

Guardian1 day

Novo Nordisk Alzheimer's drug trials fail in blow to weight-loss giant

Reuters1 day

expert reaction to news from Novo Nordisk that semaglutide does not reduce Alzheimers Disease progression

Science Media Centre1 day

Home

Bias Split Public Figures Controversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!

Sign Up Now!

About Contact Us Newsletter Archive Media

FAQ Glossary Privacy Policy

© 2025 Improve the News Foundation. All rights reserved.Version 6.18.0

© 2025 Improve the News Foundation.

All rights reserved.

Version 6.18.0